<?xml version="1.0" encoding="UTF-8"?>
<p>Similarly to ABA and TNFi, antiviral prophylaxis is warranted for HBsAg-positive patients, whereas aminotransferase monitoring (with HBV-DNA measurement in the case of AST or ALT elevation) is sufficient for HBsAg negative/anti-HBc positive patients.</p>
